MSB 3.21% $1.13 mesoblast limited

MSB Trading 2021 - paradigm shift, page-563

  1. 1,480 Posts.
    lightbulb Created with Sketch. 3255
    Hi all,

    first post. Just noticed the cited Motley Fool article, quoting Bell Potter saying:

    " The report believes that path forward is “focusing on Class II CHF patients, with reduction in morality as a primary endpoint”.

    Based on many years experience I am confident that's definitely achievable. Have a great day in the market.

    Cheers, GLTAH.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.